Assessment of higher order structure comparability in therapeutic proteins using nuclear magnetic resonance spectroscopy

被引:35
作者
Amezcua, Carlos A. [1 ]
Szabo, Christina M. [1 ]
机构
[1] Baxter Healthcare Corp, Round Lake, IL 60073 USA
关键词
Higher order structure comparability; biopharmaceuticals characterization; NMR; spectroscopy; ECHOS-NMR; NMR fingerprinting; proteins; protein structure; diffusion; NMR-SPECTROSCOPY; QUALIFICATION;
D O I
10.1002/jps.23531
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In this work, we applied nuclear magnetic resonance (NMR) spectroscopy to rapidly assess higher order structure (HOS) comparability in protein samples. Using a variation of the NMR fingerprinting approach described by Panjwani et al. [2010. J Pharm Sci 99(8):33343342], three nonglycosylated proteins spanning a molecular weight range of 6.567kDa were analyzed. A simple statistical method termed easy comparability of HOS by NMR (ECHOS-NMR) was developed. In this method, HOS similarity between two samples is measured via the correlation coefficient derived from linear regression analysis of binned NMR spectra. Applications of this method include HOS comparability assessment during new product development, manufacturing process changes, supplier changes, next-generation products, and the development of biosimilars to name just a few. We foresee ECHOS-NMR becoming a routine technique applied to comparability exercises used to complement data from other analytical techniques. (c) 2013 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 102:17241733, 2013
引用
收藏
页码:1724 / 1733
页数:10
相关论文
共 20 条
  • [1] Assessment of the three-dimensional structure of recombinant protein therapeutics by NMR fingerprinting:: Demonstration on recombinant human granulocyte macrophage-colony stimulation factor
    Aubin, Yves
    Gingras, Genevleve
    Sauve, Simon
    [J]. ANALYTICAL CHEMISTRY, 2008, 80 (07) : 2623 - 2627
  • [2] CDER, 2005, Q5E COMP BIOT BIOL P
  • [3] Characterizing biological products and assessing comparability following manufacturing changes
    Chirino, AJ
    Mire-Sluis, A
    [J]. NATURE BIOTECHNOLOGY, 2004, 22 (11) : 1383 - 1391
  • [4] *COMM MED PROD HUM, 2006, GUID SIM BIOL MED PR
  • [5] Comparability of protein therapeutics: Quantitative comparison of second-derivative amide I infrared spectra
    D'Antonio, Jennifer
    Murphy, Brian M.
    Manning, Mark Cornell
    Al-Azzam, Wasfi A.
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (06) : 2025 - 2033
  • [6] Diffusion NMR spectroscopy: Folding and aggregation of domains in p53
    Dehner, A
    Kessler, H
    [J]. CHEMBIOCHEM, 2005, 6 (09) : 1550 - 1565
  • [7] European Medicines Agency, 2005, ICH TOP Q5E COMP BIO
  • [8] Freedberg DI, 2005, DEV BIOLOGICALS, V122, P77
  • [9] Jiang Y, 2013, BIOPHYSICS THERAPEUT, P99
  • [10] Qualification of FTIR Spectroscopic Method for Protein Secondary Structural Analysis
    Jiang, Yijia
    Li, Cynthia
    Xichdao Nguyen
    Muzammil, Salman
    Towers, Ed
    Gabrielson, John
    Narhi, Linda
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (11) : 4631 - 4641